Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over 2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency Virus in France.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 05 06 2023
accepted: 14 11 2023
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: ppublish

Résumé

We assessed cumulative detection and determinants of anal high-grade squamous intraepithelial lesions (HSILs) in men who have sex with men living with human immunodeficiency virus and who underwent 3 visits over 2 years, with cytology and high-resolution anoscopy, within the ANRS-EP57-APACHES study. The cumulative HSIL detection rate was 33% (134 of 410), of which 48% HSILs were detected at baseline. HSIL detection varied considerably by center (from 13% to 51%). The strongest HSIL determinants were baseline human papillomavirus 16 (adjusted odds ratio, 8.2; 95% confidence interval, 3.6-18.9) and p16/Ki67 (4.6 [2.3-9.1]). Repeated annual cytology and high-resolution anoscopy improved HSIL detection but did not fully compensate for between-center heterogeneity.

Identifiants

pubmed: 39052708
pii: 7720834
doi: 10.1093/infdis/jiad506
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-60

Subventions

Organisme : ANRS
Organisme : France Recherche Nord et Sud SIDA-HIV Hépatites
ID : 14730

Investigateurs

Cédric Arvieux (C)
Ana Canestri (A)
Gary Clifford (G)
Jean-Damien Combes (JD)
Valérie Costes-Martineau (V)
Jean Del Grande (J)
Jean-Michel Didelot (JM)
Isabelle Etienney (I)
Michael Falguières (M)
Tristan Ferry (T)
Hugues Fischer (H)
Jean-Francois Flejou (JF)
Isabelle Heard (I)
Sébastien Henno (S)
Nadia Hoyau (N)
Marine Landon (M)
Hélène Laude (H)
Frédérique Le Breton (F)
Anne-Carole Lesage (AC)
Annie Lion (A)
Gilles Maincent (G)
Lucie Marchand (L)
Haingo Njatonirina Andrianiaina (HN)
Olivier Patey (O)
Ventzislava Petrov Sanchez (VP)
Gilles Pialoux (G)
Marion Pirel (M)
Lionel Piroth (L)
Isabelle Poizot-Martin (I)
Sylvie Radenne (S)
Emmanuelle Ressiot (E)
Jacques Reynes (J)
Laurent Siproudhis (L)
Catherine Tamalet (C)
Pierre Tattevin (P)
Olivia Zaegel-Faucher (O)

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. O. Z. F. received honoraria from Gilead for a presentation after the 2023 Conference on Retroviruses and Opportunistic Infections, as well as support from ViiV Healthcare for traveling to and attending the European AIDS Conference in October 2023 and the Société Française de Lutte contre le Sida conference in 2022. T. M. D. received grants/contracts from the U.S. National Cancer Institute for the ANCHOR study, central pathology review, and salary support to the University of California, San Francisco. C. J. A.'s employer received an unrestricted research grant from GSK for an investigator-initiated research project not related to this work. I. E. has received payment or honoraria from Merck Sharp & Dohme for an educational event for practitioners. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Jean-Damien Combes (JD)

International Agency for Research on Cancer (IARC/WHO), Early Detection, Prevention, and Infections Branch, Lyon, France.

Jean-Michel Didelot (JM)

Service d'Hépatogastroentérologie, Centre Hospitalier Universitaire Montpellier, Montpellier, France.

Sylvie Radenne (S)

Service d'Hépatologie, Hôpital de la Croix Rousse, CHU Lyon, Lyon, France.

Olivia Zaegel-Faucher (O)

Service d'Immuno-Hématologie Clinique, Université Aix Marseille, APHM Sainte-Marguerite, Marseille, France.
INSERM U912 (Sciences Économiques et Sociales de la Santé et Traitement de l'Information Médicale-SESSTIM), Université Aix Marseille, Marseille, France.

Anne-Carole Lesage (AC)

Service de Proctologie Médico-Interventionnelle, Groupe Hospitalier Diaconesses Croix-Saint-Simon, Paris, France.

Laurent Siproudhis (L)

Department of Gastroenterology, University Hospital of Rennes, Pontchaillou, Rennes, France.
INSERM U1241, University of Rennes 1, Rennes, France.
INPHY CIC 1414 University Hospital of Rennes, Pontchaillou, Rennes, France.

Lionel Piroth (L)

Département d'Infectiologie, Centre Hospitalier Universitaire (CHU) de Dijon, Dijon, France.
Institut National de la Sante et de la Recherche Medicale (INSERM), Centre d'Investigation Clinique INSERM (CIC INSERM 1432), Université de Bourgogne, Dijon, France.

Lucie Marchand (L)

Agence nationale de recherche sur le sida et les hépatites, Maladies infectieuses émergentes (ANRS-MIE), Paris, France.

Isabelle Heard (I)

Centre National de Référence des HPV, Institut Pasteur, Paris, France.
Hôpital Tenon, AP-HP, Paris, France.

Nadia Hoyeau (N)

Service d'Anatomie et Cytologie Pathologiques, Hôpital Saint-Antoine, Groupe Hospitalier Hôpitaux Universitaires Est Parisien (GH HUEP), AP-HP, Paris, France.

Sébastien Henno (S)

Service d'Anatomie et Cytologie Pathologiques, CHU Pontchaillou, Rennes, France.

Teresa M Darragh (TM)

Department of Pathology, University of California SanFrancisco, San Francisco, California, USA.

Catharina J Alberts (CJ)

International Agency for Research on Cancer (IARC/WHO), Early Detection, Prevention, and Infections Branch, Lyon, France.

Gary M Clifford (GM)

International Agency for Research on Cancer (IARC/WHO), Early Detection, Prevention, and Infections Branch, Lyon, France.

Isabelle Etienney (I)

Service de Proctologie Médico-Interventionnelle, Groupe Hospitalier Diaconesses Croix-Saint-Simon, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH